Adverse drug reactions in the orofacial region

Critical Reviews in Oral Biology and Medicine

Volumn 15, Issue 4, 2004, Pages 221-239

  Scully, C ^a   Bagan, J V ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Adverse reactions; Drugs; Mucosa; Oral; Salivary; Taste; Ulcers

Indexed keywords

ALFUZOSIN; AMFEBUTAMONE; AMILORIDE; AMITRIPTYLINE; AMOXAPINE; BENZATROPINE; BIPERIDEN; CANNABIS; CETIRIZINE; CHLORPROMAZINE; CITALOPRAM; CLEMASTINE; CLOMIPRAMINE; CLONIDINE; CLOZAPINE; CYCLIZINE; CYCLOBENZAPRINE; DESIPRAMINE; DEXAMPHETAMINE; DIAZEPAM; DICYCLOVERINE; DIDANOSINE; DIHYDROCODEINE; DISOPYRAMIDE; DOSULEPIN; DOXEPIN; DULOXETINE; ELLIPTINIUM; TRIHEXYPHENIDYL; UNINDEXED DRUG; DRUG;

AGEUSIA; ANGIONEUROTIC EDEMA; APHTHOUS ULCER; CANDIDIASIS; CHEILITIS; DESQUAMATION; DRUG ERUPTION; DYSGEUSIA; DYSTONIA; EPIDERMOLYSIS; ERYTHEMA MULTIFORME; FACE DISORDER; FACE PAIN; GINGIVA HYPERPLASIA; HALITOSIS; HUMAN; HYPERSALIVATION; HYPOGEUSIA; KAPOSI SARCOMA; LEUKOPLAKIA; LICHENOID ERUPTION; LUPUS LIKE SYNDROME; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT NEOPLASTIC DISEASE; MEDLINE; MOUTH DISEASE; MOUTH PAIN; MOUTH ULCER; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MUCOSA INFLAMMATION; MUCOSAL DISEASE; NONHODGKIN LYMPHOMA; ORAL DYSESTHESIA; OVERACTIVE BLADDER; PAPILLOMA; PARESTHESIA; PEMPHIGOID; PEMPHIGUS VULGARIS; PIGMENT DISORDER; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND DISEASE; SALIVARY GLAND PAIN; SQUAMOUS CELL CARCINOMA; STEVENS JOHNSON SYNDROME; STOMATITIS; SWELLING; SYSTEMIC LUPUS ERYTHEMATOSUS; TARDIVE DYSKINESIA; TASTE DISORDER; TONGUE HYPESTHESIA; TOOTH DISCOLORATION; TRIGEMINUS NEURALGIA; XEROSTOMIA; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GINGIVA; MOUTH MUCOSA; TRIGEMINAL NERVE DISEASE;

FACIAL PAIN; GINGIVA; HUMANS; MOUTH DISEASES; MOUTH MUCOSA; PHARMACEUTICAL PREPARATIONS; TASTE DISORDERS; TOOTH DISCOLORATION; TRIGEMINAL NERVE DISEASES;

EID: 4143141199     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/154411130401500405     Document Type: Review

References (327)

1. Abdollahi M, Radfar M (2003). A review of drug-induced oral reactions. J Contemp Dent Pract 4:10-31.
2. Ackerman BH, Kasbekar N (1997). Disturbances of taste and smell induced by drugs. Pharmacotherapy 17:482-496.
3. Adams CE, Eisenbruch M (2000). Depot fluphenazine for schizophrenia. Cochrane Database Syst Rev 2:CD000307.
4. Agbo-Godeau S, Joly P, Lauret P, Szpirglas R, Szpirglas H (1998). Association of major aphthous ulcers and nicorandil. Lancet 352:1598-1599.
5. Allen CL, Loudon J, Mascarenhas AK (2001). Sanguinaria-related leukoplakia: epidemiologic and clinicopathologic features of a recently described entity. Gen Dent 49:608-614.
6. Anttila SA, Leinonen EV (2001). A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 7:249-264.
7. Atkinson JC, Shiroky JB, Macynski A, Fox PC (1989). Effects of furosemide on the oral cavity. Gerodontology 8:23-26.
8. Axéll T, Spiechowicz E, Glantz PO, Andersson G, Larsson A (1986). A new method for intraoral patch testing. Contact Dermatitis 15:58-62.
9. Ayangco L, Rogers RS III (2003). Oral manifestations of erythema multiforme. Dermatol Clin 21:195-205.
10. Bell KA, Perna AG, Hsu S (2001). Mucositis as a treatment-limiting side effect in the use of capecitabine for the treatment of metastatic breast cancer. J Am Acad Dermatol 45:790-791.
11. Bergdahl M, Bergdahl J (2000). Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res 79:1652-1658.
12. Bilinska-Pietraszek E, Namyslowski G, Mrowka-Kata K, Scierski W, Aniol-Borkowska M (2001). [A case of tongue neoplasm in a 15-year old patient treated with immunosuppressants for renal insufficiency]. Otolaryngol Pol 55:95-97.
13. Bircher AJ, von Schulthess A, Henning G (1993). Oral lichenoid lesions and mercury sensitivity. Contact Dermatitis 29:275-276.
14. Bolewska J, Hansen HJ, Holmstrup P, Pindborg JJ, Stangerup M (1990). Oral mucosal lesions related to silver amalgam restorations. Oral Surg Oral Med Oral Pathol 70:55-58.
15. Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, et al. (2002). Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord 26:593-604.
16. Bosch JA, Valdes M, Oristrell J, Pigrau C, Ordi J (1985). Oxyphenbutazone-induced sialadenitis, intrahepatic cholestasis and pancreatitis. Acta Gastroenterol Belg 48:529-530.
17. Boulinguez S, Bedane C, Bouyssou-Gauthier ML, Cornee-Leplat I, Truong E, Bonnetblanc JM (1997). [Giant buccal aphthosis caused by nicorandil]. Presse Med 26(12):558.
18. Boulinguez S, Reix S, Bedane C, Debrock C, Bouyssou-Gauthier ML, Sparsa A, et al. (2000). Role of drug exposure in aphthous ulcers: a case-control study. Br J Dermatol 143:1261-1265.
19. Bowman JM, Levy BA, Grubb RV (1988). Gingival overgrowth induced by diltiazem. A case report. Oral Surg Oral Med Oral Pathol 65:183-185.
20. Boyd LD, Dwyer JT, Papas A (1997). Nutritional implications of xerostomia and rampant caries caused by serotonin reuptake inhibitors: a case study. Nutr Rev 55:362-368.
21. Bratel J, Hakeberg M, Jontell M (1996). Effect of replacement of dental amalgam on oral lichenoid reactions. J Dent 24:41-45.
22. Bray GA (2001). Drug treatment of obesity. Rev Endocr Metab Disord 2:403-418.
23. Brenner S, Bialy-Golan A, Anhalt GJ (1997). Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol 36:919-923.
24. Brenner S, Bialy-Golan A, Ruocco V (1998). Drug-induced pemphigus. Clin Dermatol 16:393-397.
25. British National Formulary (2002). Antituberculous drugs. In: British National Forumulary. British Medical Association and Royal Pharmaceutical Society of Great Britain, pp. 290-291.
26. Brown RS, Hays GL, Flaitz CM (1993). Treatment of gold salt-induced oral lichen planus: report of a case. Cutis 51:183-185.
27. Bruera E, Belzile M, Neumann CM, Ford I, Harsanyi Z, Darke A (1999). Twice-daily versus once-daily morphine sulphate controlled-release suppositories for the treatment of cancer pain. A randomized controlled trial. Support Care Cancer 7:280-283.
28. Bucknall CA, Keeton BR, Curry PV, Tynan MJ, Sutherland GR, Holt DW (1986). Intravenous and oral amiodarone for arrhythmias in children. Br Heart J 56:278-284.
29. Burlingame RW, Rubin RL (1996). Autoantibody to the nucleosome subunit (H2A-H2B)-DNA is an early and ubiquitous feature of lupus-like conditions. Mol Biol Rep 23:159-166.
30. Busto UE, Sproule BA, Knight K, Herrmann N (2001). Use of prescription and nonprescription hypnotics in a Canadian elderly population. Can J Clin Pharmacol 8:213-221.
31. Casaburi R, Briggs DD Jr, Donohue JF, Serby CW, Menjoge SS, Witek TJ Jr (2000). The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. Chest 118:1294-1302.
32. Cebeci I, Kantarci A, Firatli E, Carin M, Tuncer O (1996). The effect of verapamil on the prevalence and severity of cyclosporine-induced gingival overgrowth in renal allograft recipients. J Periodontol 67:1201-1205.
33. Chacko RC, Marsh BJ, Marmion J, Dworkin RJ, Telschow R (1987). Lithium side effects in elderly bipolar outpatients. Hillside J Clin Psychiatry 9:79-88.
34. Chau NY, Reade PC, Rich AM, Hay KD (1984). Allopurinol-amplified lichenoid reactions of the oral mucosa. Oral Surg Oral Med Oral Pathol 58:397-400.
35. Chi KH, Myers JN, Chow KC, Chan WK, Tsang YW, Chao Y, et al. (2001). Phase II trial of systemic recombinant interleukin-2 in the treatment of refractory nasopharyngeal carcinoma. Oncology 60:110-115.
36. Chimenes H (1971). [Phenylbutazone derivatives and pathology of the salivary glands]. Presse Med 79(2):54.
37. Christodoulou GN, Siafakas A, Rinieris PM (1977). Side-effects of lithium. Acta Psychiatr Belg 77:260-266.
38. Clemett D, Jarvis B (2001). Tolterodine: a review of its use in the treatment of overactive bladder. Drugs Aging 18:277-304.
39. Cohen L, Banks P (1966). Salivary gland enlargement and phenylbutazone. Br Med J 5500:1420.
40. Colvard MD, Nadimi H, Gargiulo AV (1986). Ativan (lorazepam) induced lichenoid reaction of the human attached gingiva: case report. Periodontal Case Rep 8:69-70.
41. Comley C, Galletly C, Ash D (2000). Use of atropine eye drops for clozapine induced hypersalivation. Aust NZ J Psychiatry 34:1033-1034.
42. Conklin RJ, Blasberg B (1987). Oral lichen planus. Dermatol Clin 5:663-673.
43. Consroe P, Sandyk R, Snider SR (1986). Open label evaluation of cannabidiol in dystonic movement disorders. Int J Neurosci 30:277-282.
44. Conti L, Pinder RM (1979). A controlled comparative trial of mianserin and diazepam in the treatment of anxiety states in psychiatric out-patients. J Int Med Res 7:285-289.
45. Corone S, Davido A, Corone P (1987). [A rare complication of captopril: ulceration of the lingual and jugal mucosae]. Rev Med Interne 8:73-74.
46. Cotler SJ, Wartelle CF, Larson AM, Gretch DR, Jensen DM, Carithers RL Jr (2000). Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C. J Viral Hepat 7:211-217.
47. Cribier B, Marquart-Elbaz C, Lipsker D, Alt M, Grosshans E (1998). Chronic buccal ulceration induced by nicorandil. Br J Dermatol 138:372-373.
48. Damm DD, Curran A, White DK, Drummond JF (1999). Leukoplakia of the maxillary vestibule - an association with Viadent? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87:61-66.
49. Davies AN, Broadley K, Beighton D (2001). Xerostomia in patients with advanced cancer. J Pain Symptom Manage 22:820-825.
50. Davis R, Faulds D (1996). Dexfenfluramine. An updated review of its therapeutic use in the management of obesity. Drugs 52:696-724.
51. Desruelles F, Bahadoran P, Lacour JP, Perrin C, Santini J, Ortonne JP (1998). Giant oral aphthous ulcers induced by nicorandil. Br J Dermatol 138:712-713.
52. Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA (2002). Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry 63:308-315.
53. Di Giovanni J (1990). Drugs and the geriatric patient: a review of problems and special considerations faced by the dentist. Spec Care Dentist 10:161-163.
54. Dickstein K, Manhenke C, Aarsland T, McNay J, Wiltse C, Wright T (2000). The effects of chronic, sustained-release moxonidine therapy on clinical and neurohumoral status in patients with heart failure. Int J Cardiol 75:167-176.
55. Diederich NJ, Goetz CG (1998). Drug-induced movement disorders. Neurol Clin 16:125-139.
56. Dinsdale RC, Walker AE (1966). Amiphenazole sensitivity with oral ulceration. Br Dent J 121:460-462.
57. Dodd CL, Greenspan D, Westenhouse JL, Katz MH (1992). Xerostomia associated with didanosine. Lancet 340(8822):790.
58. Dolberg OT, Klag E, Gross Y, Schreiber S (2002). Relief of serotonin selective reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury. Psychopharmacology (Berl) 161:404-407.
59. Downham TF III (1978). Spironolactone-induced lichen planus. J Am Med Assoc 240(11):1138.
60. Dreizen S, Keating MJ, Beran M (1992). Orofacial fungal infections. Nine pathogens that may invade during chemotherapy. Postgrad Med 91:349-357.
61. Duggan L, Fenton M, Dardennes RM, El Dosoky A, Indran S (2000). Olanzapine for schizophrenia. Cochrane Database Syst Rev (2):CD001359.
62. Ebo DG, Stevens WJ (1997). Angioedema of ACE inhibitors. Allergy 52:354-355.
63. Eisen D (1993). Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: an open trial. J Am Acad Dermatol 28:609-612.
64. Elie R, Lamontagne Y (1984). Alprazolam and diazepam in the treatment of generalized anxiety. J Clin Psychopharmacol 4:125-129.
65. Ellingrod VL, Perry PJ (1994). Venlafaxine: a heterocyclic antidepressant. Am J Hosp Pharm 51:3033-3046.
66. Ellis JS, Seymour RA, Thomason JM, Monkman SC, Idle JR (1993). Gingival sequestration of amlodipine and amlodipine-induced gingival overgrowth. Lancet 341:1102-1103.
67. Eversole LR, Ringer M (1984). The role of dental restorative metals in the pathogenesis of oral lichen planus. Oral Surg Oral Med Oral Pathol 57:383-387.
68. Fattore L, Stablein M, Bredfeldt G, Semla T, Moran M, Doherty-Greenberg JM (1991). Gingival hyperplasia: a side effect of nifedipine and diltiazem. Spec Care Dentist 11:107-109.
69. Feighner JP (1999). Mechanism of action of antidepressant medications. J Clin Psychiatry 60(Suppl 4):4-11.
70. Feighner JP, Overo K (1999). Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. J Clin Psychiatry 60:824-830.
71. Femiano F, Scully C, Gombos F (2002). Idiopathic dysgeusia; an open trial of alpha lipoic acid (ALA) therapy. Int J Oral Maxillofac Surg 31:625-628.
72. Femiano F, Scully C, Gombos F (2003). Linear IgA dermatosis induced by a new angiotensin-converting enzyme inhibitor. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:169-173.
73. Ficarra G, Shillitoe EJ, Adler-Storthz K, Gaglioti D, Di Pietro M, Riccardi R, et al. (1990). Oral melanotic macules in patients infected with human immunodeficiency virus. Oral Surg Oral Med Oral Pathol 70:748-755.
74. Field EA, Fear S, Higham SM, Ireland RS, Rostron J, Willetts RM, et al. (2001). Age and medication are significant risk factors for xerostomia in an English population, attending general dental practice. Gerodontology 18:21-24.
75. Finne K, Goransson K, Winckler L (1982). Oral lichen planus and contact allergy to mercury. Int J Oral Surg 11:236-239.
76. Firth NA, Reade PC (1989). Angiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactions. Oral Surg Oral Med Oral Pathol 67:41-44.
77. Flageul B, Foldes C, Wallach D, Vignon-Pennamen MD, Cottenot F (1986). Captopril-induced lichen planus pemphigoides with pemphigus-like features. A case report. Dermatologica 173:248-255.
78. Ford B, Greene P, Fahn S (1994). Oral and genital tardive pain syndromes. Neurology 44:2115-2119.
79. Fox PC (1998). Acquired salivary dysfunction. Drugs and radiation. Ann NY Acad Sci 842:132-137.
80. Freye E, Baranowski J, Latasch L (2001). Dose-related effects of controlled release dihydrocodeine on oro-cecal transit and pupillary light reflex. A study in human volunteers. Arzneimittelforschung 51:60-66.
81. Friedlander AH, Birch NJ (1990). Dental conditions in patients with bipolar disorder on long-term lithium maintenance therapy. Spec Care Dentist 10:148-151.
82. Gabb GM, Ryan P, Wing LM, Hutchinson KA (1996). Epidemiological study of angioedema and ACE inhibitors. Aust NZ J Med 26:777-782.
83. Gall Y, Guillet G, Leroy JP, Masse R, Guillet MH (1986). [Bullae and urticaria-like lesions of allergic vasculitis with immunomarkers of the bullous pemphigoid type during treatment with D-penicillamine]. Ann Dermatol Venereol 113:55-58.
84. Gange RW, Rhodes EL, Edwards CO, Powell ME (1976). Pemphigus induced by rifampicin. Br J Dermatol 95:445-448.
85. Gattoni F, Pozzato C, Padovese P, Rizzi AM, Brancaccio D, Uslenghi C (1991). [Salivary gland enlargement caused by intravenous iodinated contrast medium. Description of a case]. Radiol Med (Torino) 81:162-163.
86. Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E (2000). Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: a 6-month randomized controlled trial. J Am Med Assoc 283:3082-3088.
87. Giansanti JS, Tillery DE, Olansky S (1971). Oral mucosal pigmentation resulting from antimalarial therapy. Oral Surg Oral Med Oral Pathol 31:66-69.
88. Gibson LE, van Hale HM, Schroeter AL (1986). Direct immunofluorescence for the study of cutaneous drug eruptions. Acta Derm Venereol 66:39-44.
89. Glass BJ (1989). Drug-induced xerostomia as a cause of glossodynia. Ear Nose Throat J 68(10):776-781.
90. Glover J, Dibble S, Miaskowski C, Geibert R (1995). Changes in taste associated with intravenous administration of pentamidine. J Assoc Nurses AIDS Care 6:43-48.
91. Goldberg I, Kashman Y, Brenner S (1999). The induction of pemphigus by phenol drugs. Int J Dermatol 38:888-892.
92. Gonzalez-Moles MA, Bagan-Sebastian JV (2000). Alendronate-related oral mucosa ulcerations. J Oral Pathol Med 29:514-518.
93. Goodman GE, Alberts DS, Earnst DL, Meyskens FL (1983). Phase I trial of retinol in cancer patients. J Clin Oncol 1:394-399.
94. Gordon CR, Gonen A, Nachum Z, Doweck I, Spitzer O, Shupak A (2001). The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance. J Psychopharmacol 15:167-172.
95. Greco S, Mazzaglia G, Caputi AP, Pagliaro L (1997). Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics. Ann Pharmacother 31:1548.
96. Greenberg MS, Friedman H, Cohen SG, Oh SH, Laster L, Starr S (1987). A comparative study of herpes simplex infections in renal transplant and leukemic patients. J Infect Dis 156:280-287.
97. Greenwood I, Heylen R, Zakrzewska JM (1998). Anti-retroviral drugs - implications for dental prescribing. Br Dent J 184:478-482.
98. Gregoriou AP, Schneider PE, Shaw PR (1996). Phenobarbital-induced gingival overgrowth? Report of two cases and complications in management. ASDC J Dent Child 63:408-413.
99. Griffin JP (1992). Drug-induced disorders of taste. Adverse Drug React Toxicol Rev 11:229-239.
100. Grotenhermen F (1999). [The effects of cannabis and THC]. Forsch Komplementarmed 6(Suppl 3):7-11.
101. Guasti L, Grimoldi P, Diolisi A, Petrozzino MR, Gaudio G, Grandi AM, et al. (1998). Treatment with enalapril modifies the pain perception pattern in hypertensive patients. Hypertension 31:1146-1150.
102. Gwaltney JM Jr, Park J, Paul RA, Edelman DA, O'Connor RR, Turner RB (1996). Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds. Clin Infect Dis 22:656-662.
103. Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, et al. (2001). Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34:84-91.
104. Haas DA, Lennon D (1995). A 21 year retrospective study of reports of paresthesia following local anesthetic administration. J Canad Dent Assoc 61:319-330.
105. Hakala M, van Assendelft AH, Ilonen J, Jalava S, Tiilikainen A (1986). Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis. Ann Rheum Dis 45:177-182.
106. Halpern SM, Todd PM, Kirby JD (1996). Loss of taste associated with isotretinoin. Br J Dermatol 134:378.
107. Hansen TE, Casey DE, Hoffman WF (1997). Neuroleptic intolerance. Schizophr Bull 23:567-582.
108. Hatlebakk JG, Nesje LB, Hausken T, Bang CJ, Berstad A (1995). Lansoprazole capsules and amoxicillin oral suspension in the treatment of peptic ulcer disease. Scand J Gastroenterol 30:1053-1057.
109. Hay-Smith J, Herbison P, Ellis G, Moore K (2002). Anticholinergic drugs versus placebo for overactive bladder syndrome in adults (Cochrane Review). Cochrane Database Syst Rev (3):CD003781.
110. Healy CM, Thornhill MH (1995). An association between recurrent oro-genital ulceration and non-steroidal anti-inflammatory drugs. J Oral Pathol Med 24:46-48.
111. Henkin RI (1994). Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Safety 11:318-327.
112. Hennes R, Mack A, Schell H, Vogt HJ (1984). 13-cis-retinoic acid in conglobate acne. A follow-up study of 14 trial centers. Arch Dermatol Res 276:209-215.
113. Henriksson E, Mattsson U, Hakansson J (1995). Healing of lichenoid reactions following removal of amalgam. A clinical follow-up. J Clin Periodontol 22:287-294.
114. Herlofson BB, Barkvoll P (1994). Sodium lauryl sulfate and recurrent aphthous ulcers. A preliminary study. Acta Odontol Scand 52:257-259.
115. Herman I, Schwartz Y, Bassan H (1974). [Primary cardiac involvement and painful salivary gland enlargement due to phenylbutazone]. Harefuah 86:246-247.
116. Hernandez G, Jimenez C, Arriba L, Moreno E, Lucas M (2001). Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:526-531.
117. Hernandez G, Arriba L, Jimenez C, Bagan JV, Rivera B, Lucas M, et al. (2003). Rapid progression from oral leukoplakia to carcinoma in an immunosuppressed liver transplant recipient. Oral Oncol 39:87-90.
118. Hertz RS, Beckstead PC, Brown WJ (1980). Epithelial melanosis of the gingiva possibly resulting from the use of oral contraceptives. J Am Dent Assoc 100:713-714.
119. Heymann WR (2000). Psychotropic agent-induced black hairy tongue. Cutis 66:25-26.
120. Hietanen J, Pihlman K, Forstrom L, Linder E, Reunala T (1987). No evidence of hypersensitivity to dental restorative metals in oral lichen planus. Scand J Dent Res 95:320-327.
121. Hogan DJ, Murphy F, Burgess WR, Epstein JD, Lane PR (1985). Lichenoid stomatitis associated with lithium carbonate. J Am Acad Dermatol 13:243-246.
122. Holmstrup P (1991). Reactions of the oral mucosa related to silver amalgam: a review. J Oral Pathol Med 20:1-7.
123. Hsi ED, Singleton TP, Swinnen L, Dunphy CH, Alkan S (2000). Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients. Am J Surg Pathol 24:100-106.
124. Hunter KD, Wilson WS (1995). The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva. Arch Oral Biol 40:983-989.
125. Ibbotson SH, Speight EL, Macleod RI, Smart ER, Lawrence CM (1996). The relevance and effect of amalgam replacement in subjects with oral lichenoid reactions. Br J Dermatol 134:420-423.
126. Ilia R, Aizenberg O, Moshe G (1991). Salivary gland enlargement following renografin injection may be secondary to hypersensitivity. Cathet Cardiovasc Diagn 23:69-70.
127. Ingafou M, Lodi G, Olsen I, Porter SR (1997). Oral lichen planus is not associated with IgG circulating antibodies to epithelial antigens. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:175-178.
128. Jaber MA, Porter SR, Scully C, Gilthorpe MS, Bedi R (1998). The role of alcohol in non-smokers and tobacco in non-drinkers in the aetiology of oral epithelial dysplasia. Int J Cancer 77:333-336.
129. Jackson C, Babich S (1997). Gingival hyperplasia: interaction between cyclosporin A and nifedipine? A case report. NY State Dent J 63:46-48.
130. Jacquetin B, Wyndaele J (2001). Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder. Eur J Obstet Gynecol Reprod Biol 98:97-102.
131. James J, Ferguson MM, Forsyth A, Tulloch N, Lamey PJ (1987). Oral lichenoid reactions related to mercury sensitivity. Br J Oral Maxillofac Surg 25:474-480.
132. Jameson MW, Kardos TB, Kirk EE, Ferguson MM (1990). Mucosal reactions to amalgam restorations. J Oral Rehabil 17:293-301.
133. Jimenez-Jimenez FJ, Garcia-Ruiz PJ, Molina JA (1997). Drug-induced movement disorders. Drug Safety 16:180-204.
134. Johnston JA, Fiedler-Kelly J, Glover ED, Sachs DP, Grasela TH, DeVeaugh-Geiss J (2001). Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation. Nicotine Tob Res 3:131-140.
135. Jolly M, Moule AJ, Bryant RW, Freeman S (1986). Amalgam-related chronic ulceration of oral mucosa. Br Dent J 160:434-437.
136. Kaiser HB, Banov CH, Berkowitz RR, Bernstein DI, Bronsky EA, Georgitis JW, et al. (1998). Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis. Am J Ther 5:245-251.
137. Kaplan RP, Potter TS, Fox JN (1992). Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors. J Am Acad Dermatol 26:364-366.
138. Katz J, Givol N, Chaushu G, Taicher S, Shemer J (1997). Vigabatrin-induced gingival overgrowth. J Clin Periodontol 24:180-182.
139. Kaufman E, Garfunkel AA, Tzukert A (1977). [Acute sialadenitis due to butazolidin]. Harefuah 93:405-406.
140. Kaviani MJ, Malekzadeh R, Vahedi H, Sotoudeh M, Kamalian N, Amini M, et al. (2001). Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial. Eur J Gastroenterol Hepatol 13:915-919.
141. Kawaguchi M, Yamagishi H (1995). [Receptive systems for drugs in salivary gland cells]. Nippon Yakurigaku Zasshi 105:295-303.
142. Kedici PS, Memikoglu MM, Kansu G, Isimer A, Gunhan O (1995). Case report: ionisation tendency of a base metal alloy in the oral environment. Eur J Prosthodont Restor Dent 3:231-234.
143. Keogh PV, Fisher V, Flint SR (2002). Resolution of oral non-Hodgkin's lymphoma by reduction of immunosuppressive therapy in a renal allograft recipient: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:697-701.
144. King GN, Healy CM, Glover MT, Kwan JT, Williams DM, Leigh IM, et al. (1995). Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients. N Engl J Med 332:1052-1057.
145. Kirby JD, Black M, McGibbon D (1980). Levamisole-induced lichenoid eruptions. J R Soc Med 73:208-211.
146. Knulst AC, Stengs CJ, Baart DF, Graamans K, Hene RJ, Collet JT, et al. (1995). Salivary gland swelling following naproxen therapy. Br J Dermatol 133:647-649.
147. Korman NJ, Eyre RW, Zone J, Stanley JR (1991). Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol 96:273-276.
148. Kuechle MK, Stegemeir E, Maynard B, Gibson LE, Leiferman KM, Peters MS (1994). Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. J Am Acad Dermatol 30:187-192.
149. Kuttan NA, Narayana N, Moghadam BK (2001). Desquamative stomatitis associated with routine use of oral health care products. Gen Dent 49:596-602.
150. Lader MH (1996). Tolerability and safety: essentials in antidepressant pharmacotherapy. J Clin Psychiatry 57(Suppl 2):39-44.
151. Laeijendecker R, van Joost T (1994). Oral manifestations of gold allergy. J Am Acad Dermatol 30:205-209.
152. Laine K, Tybring G, Hartter S, Andersson K, Svensson JO, Widen J, et al. (2001). Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test. Clin Pharmacol Ther 70:327-335.
153. Laine P, Meurman JH, Tenovuo J, Murtomaa H, Lindqvist C, Pyrhonen S, et al. (1992). Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs. Eur J Cancer B Oral Oncol 28(B):125-128.
154. Lamey PJ, Gibson J, Barclay SC, Miller S (1990). Grinspan's syndrome: a drug-induced phenomenon? Oral Surg Oral Med Oral Pathol 70:184-185.
155. Lamey PJ, McCartan BE, MacDonald DG, MacKie RM (1995). Basal cell cytoplasmic autoantibodies in oral lichenoid reactions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79:44-49.
156. Lapostolle F, Borron SW, Bekka R, Baud FJ (1998). Lingual angioedema after perindopril use. Am J Cardiol 81:523.
157. Laskaris G, Nicolis G (1980). Immunopathology of oral mucosa in bullous pemphigoid. Oral Surg Oral Med Oral Pathol 50:340-345.
158. Laskaris G, Satriano RA (1993). Drug-induced blistering oral lesions. Clin Dermatol 11:545-550.
159. Layton D, Pearce GL, Shakir SA (2001). Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring. Drug Safety 24:703-713.
160. Lee E, Lee C (1997). Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses. Br J Urol 80:606-611.
161. Lind PO, Hurlen B (1988). Desquamative gingivitis responding to treatment with tetracycline: a pilot study. Scand J Dent Res 96:232-234.
162. Lind PO, Hurlen B, Lyberg T, Aas E (1986). Amalgam-related oral lichenoid reaction. Scand J Dent Res 94:448-451.
163. Loesche WJ, Bromberg J, Terpenning MS, Bretz WA, Dominguez BL, Grossman NS, et al. (1995). Xerostomia, xerogenic medications and food avoidances in selected geriatric groups. J Am Geriatr Soc 43:401-407.
164. Lombardi ML, De Angelis E, Rossano F, Ruocco V (1993). Imbalance between plasminogen activator and its inhibitors in thiol-induced acantholysis. Dermatology 186:118-122.
165. Lyell A (1979). Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol 100:69-86.
166. Madersbacher H, Halaska M, Voigt R, Alloussi S, Hofner K (1999). A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence. BJU Int 84:646-651.
167. Madinier I, Jehl-Pietri C, Monteil RA (1997). [Drug-induced xerostomia]. Ann Med Interne (Paris) 148:398-405.
168. Mahboob A, Haroon TS (1998). Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 37:833-838.
169. Maillefert JF, Farge P, Gazet-Maillefert MP, Tavernier C (1997). Mental nerve neuropathy as a result of hepatitis B vaccination. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83:663-664.
170. Mandel L, Surattanont F, Dourmas M (2001). T-cell lymphoma in the parotid region after cardiac transplant: case report. J Oral Maxillofac Surg 59:673-677.
171. Mandel SJ, Mandel L (2003). Radioactive iodine and the salivary glands. Thyroid 13:265-271.
172. Mangrella M, Motola G, Russo F, Mazzeo F, Giassa T, Falcone G, et al. (1998). [Hospital intensive monitoring of adverse reactions of ACE inhibitors]. Minerva Med 89:91-97.
173. Manor A, Sperling I, Buchner A (1981). Gingival pigmentation associated with antimalarial drugs. Refuat Hapeh Vehashinayim 28(4):13-16.
174. Markitziu A, Katz J, Pisanty S (1986). Lichenoid lesions of oral mucosa associated with ketoconazole. Mykosen 29:317-322.
175. Marquart-Elbaz C, Lipsker D, Grosshans E, Cribier B (1999). [Oral ulcers induced by nicorandil: prevalence and clinicopathological aspects]. Ann Dermatol Venereol 126:587-590.
176. Marshall RI, Bartold PM (1998). Medication induced gingival overgrowth. Oral Dis 4:130-151.
177. Mascarenhas AK, Allen CM, Loudon J (2001). The association between Viadent use and oral leukoplakia. Epidemiology 12:741-743.
178. Mascarenhas AK, Allen CM, Moeschberger ML (2002). The association between Viadent use and oral leukoplakia - results of a matched case-control study. J Public Health Dent 62:158-162.
179. Mattila MJ, Paakkari I (1999). Variations among non-sedating antihistamines: are there real differences? Eur J Clin Pharmacol 55:85-93.
180. Mattingly G, Rodu B, Alling R (1993). Quinke's disease: nonhereditary angioneurotic edema of the uvula. Oral Surg Oral Med Oral Pathol 75:292-295.
181. Matz H, Bialy-Golan A, Brenner S (1997). Diclofenac: a new trigger of pemphigus vulgaris? Dermatology 195:48-49.
182. McAllan LH, Adkins KF (1986). Drug-induced palatal pigmentation. Aust Dent J 31:1-4.
183. McCarron DA (1984). Step-one antihypertensive therapy: a comparison of a centrally acting agent and a diuretic. J Cardiovasc Pharmacol 6(Suppl 5):S853-S858.
184. McCartan BE, McCreary CE (1997). Oral lichenoid drug eruptions. Oral Dis 3:58-63.
185. McCarthy GM, Skillings JR (1991). A prospective cohort study of the orofacial effects of vincristine neurotoxicity. J Oral Pathol Med 20:345-349.
186. McCarthy GM, Skillings JR (1992). Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer. Oral Surg Oral Med Oral Pathol 74:299-304.
187. McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI (1998). Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 34:484-490.
188. McQueen A, Behan WM (1982). Immunofluorescence microscopy. The "string of pearls" phenomenon - an immunofluorescent serological finding in patients screened for adverse drug reactions. Am J Dermatopathol 4:155-159.
189. Meurman JH, Collin HL, Niskanen L, Toyry J, Alakuijala P, Keinanen S, et al. (1998). Saliva in non-insulin-dependent diabetic patients and control subjects: the role of the autonomic nervous system. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:69-76.
190. Meyers AD, Barker C, Grossman R, Potsic WP, Jafek BW (1976). Kaposi's sarcoma of the oropharynx following renal transplantation. Trans Am Acad Ophthalmol Otolaryngol 82:560-562.
191. Meyerson MA, Cohen PR, Hymes SR (1995). Lingual hyperpigmentation associated with minocycline therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79:180-184.
192. Miller RL, Gould AR, Bernstein ML (1992). Cinnamon-induced stomatitis venenata, clinical and characteristic histopathologic features. Oral Surg Oral Med Oral Pathol 73:708-716.
193. Milosevic A, Agrawal N, Redfearn P, Mair L (1999). The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymethamphetamine). Community Dent Oral Epidemiol 27:283-287.
194. Mirbod SM, Ahing SI (2000). Tobacco-associated lesions of the oral cavity: part I. Nonmalignant lesions. J Can Dent Assoc 66:252-256.
195. Mobacken H, Hersle K, Sloberg K, Thilander H (1984). Oral lichen planus: hypersensitivity to dental restoration material. Contact Dermatitis 10:11-15.
196. Montoner F, Ortiz M, Capella D, Ruiz J (1990). [Aphthous stomatitis due to captopril]. Aten Primaria 7:79.
197. Mullen J, Jibson MD, Sweitzer D (2001). A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study. Clin Ther 23:1839-1854.
198. Murray-Bruce DJ (1966). Salivary gland enlargement and phenylbutazone. Br Med J 5503:1599-1600.
199. Nagler RM (1998). Effects of radiotherapy and chemotherapeutic cytokines on a human salivary cell line. Anticancer Res 18(1A):309-314.
200. Närhi TO, Meurman JH, Ainamo A (1999). Xerostomia and hyposalivation: causes, consequences and treatment in the elderly. Drugs Aging 15:103-116.
201. Nederfors T (1996). Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists. Swed Dent J 116(Suppl):1-70.
202. Nicholls MG, Maslowski AH, Ikram H, Espiner EA (1981). Ulceration of the tongue: a complication of captopril therapy. Ann Intern Med 94:659.
203. Noguchi K, Masuda M, Noguchi S, Kubota Y, Hosaka M, Senga Y, et al. (1998). [Long-term administration study of propiverine hydrochloride (BUP-4 tablets) in pollakiuria and urinary incontinence]. Hinyokika Kiyo 44:687-693.
204. Ogunwande SA (1989). Halitosis and abuse of antibiotics. Report of a case. Ceylon Med J 34:131-133.
205. Oikarinen K, Salo T, Kylmaniemi M, Palatsi R, Karhunen T, Oikarinen A (1995). Systemic oral isotretinoin therapy and flow rate, pH, and matrix metalloproteinase-9 activity of stimulated saliva. Acta Odontol Scand 53:369-371.
206. Ong CS, Cook N, Lee S (2000). Drug-related pemphigus and angiotensin converting enzyme inhibitors. Australas J Dermatol 41:242-246.
207. Ostman PO, Anneroth G, Skoglund A (1994). Oral lichen planus lesions in contact with amalgam fillings: a clinical, histologic, and immunohistochemical study. Scand J Dent Res 102:172-179.
208. Pajukoski H, Meurman JH, Halonen P, Sulkava R (2001). Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:641-649.
209. Palmer RA, Ogg G, Allen J, Banerjee A, Ryatt KS, Ratnavel R, et al. (2001). Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285. Br J Dermatol 145:816-820.
210. Parker M (1975). Persistent parotid pain due to guanacline. Eur J Clin Pharmacol 8:131-134.
211. Parry J, Porter SL, Scully C, Flint SR, Parry MG (1996). Mucosal lesions due to cocaine use. Br Dent J 180:462-464.
212. Penneys NS, Ackerman AB, Gottlieb NL (1974). Gold dermatitis. A clinical and histopathological study. Arch Dermatol 109:372-376.
213. Pernu HE, Oikarinen K, Hietanen J, Knuuttila M (1989). Verapamil-induced gingival overgrowth: a clinical, histologic, and biochemic approach. J Oral Pathol Med 18:422-425.
214. Peroutka SJ, Newman H, Harris H (1988). Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1:273-277.
215. Persson RE, Izutsu KT, Truelove EL, Persson R (1991). Differences in salivary flow rates in elderly subjects using xerostomatic medications. Oral Surg Oral Med Oral Pathol 72:42-46.
216. Pindborg JJ, Reibel J, Roed-Peterson B, Mehta FS (1980). Tobacco-induced changes in oral leukoplakic epithelium. Cancer 45:2330-2336.
217. Pomara N, Shao B, Choi SJ, Tun H, Suckow RF (2001). Sex-related differences in nortriptyline-induced side-effects among depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 25:1035-1048.
218. Porter SR, Glover S, Scully C (1990). Oral hyperpigmentation and adrenocortical hypofunction in a patient with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 70:59-60.
219. Potgieter GE, Groenewoud G, Jordaan PJ, Hundt HK, Schall R, Kummer M, et al. (2002). Pharmacokinetics of pipamperone from three different tablet formulations. Arzneimittelforschung 52:430-434.
220. Potts AJ, Hamburger J, Scully C (1987). The medication of patients with oral lichen planus and the association of nonsteroidal antiinflammatory drugs with erosive lesions. Oral Surg Oral Med Oral Pathol 64:541-543.
221. Pradalier A, Dry J, Baron JF (1982). [Aphthoid stomatitis induced by labetalol]. Therapie 37:695-697.
222. Price EJ, Venables PJ (1995). Drug-induced lupus. Drug Safety 12:283-290.
223. Qunibi WY, Akhtar M, Ginn E, Smith P (1988). Kaposi's sarcoma in cyclosporine-induced gingival hyperplasia. Am J Kidney Dis 11:349-352.
224. Ramadan AE (1969). The association of black hairy tongue with toothpastes containing neomycin. Report of two cases. Egypt Dent J 15:253-256.
225. Rasmussen HB, Jepsen LV, Brandrup F (1989). Penicillamine-induced bullous pemphigoid with pemphigus-like antibodies. J Cutan Pathol 16:154-157.
226. Raut A, Huryn J, Pollack A, Zlotolow I (2000). Unusual gingival presentation of post-transplantation lymphoproliferative disorder: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:436-441.
227. Ravindran AV, Judge R, Hunter BN, Bray J, Morton NH (1997). A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group. J Clin Psychiatry 58:112-118.
228. Read SJ, Crawford DH, Pender MP (1995). Trigeminal sensory neuropathy induced by interferon-alpha therapy. Aust NZ J Med 25:54.
229. Rees SR, Gibson J (1997). Angioedema and swellings of the orofacial region. Oral Dis 3:39-42.
230. Reichart PA (1997). Oral ulcerations in HIV infection. Oral Dis 3(Suppl 1):S180-S182.
231. Reid JL (2001). Update on rilmenidine: clinical benefits. Am J Hypertens 14:322S-324S.
232. Rich MW (1996). Drug-induced lupus. The list of culprits grows. Postgrad Med 100:299-308.
233. Richter WO (1999). [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine]. MMW Fortschr Med 141(49-50):32-36.
234. Roberts DL, Marks R (1981). Skin reactions to carbamazepine. Arch Dermatol 117:273-275.
235. Robertson WD, Wray D (1992). Ingestion of medication among patients with oral keratoses including lichen planus. Oral Surg Oral Med Oral Pathol 74:183-185.
236. Roger M, Gerard D, Leger JM (1998). [Value of tiapride for agitation in the elderly. Review of published studies]. Encephale 24:462-468.
237. Roujeau JC (1997). Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol 24:726-729.
238. Roussel S, Courville P, Peron JM, Delcampe P, Metayer J (1998). [Oral aphthae induced by nicorandil. Anatomopathologic aspects. A propos of a case]. Rev Stomatol Chir Maxillofac 99:207-209.
239. Ruocco V, Brenner S, Lombardi ML (1996). A case of diet-related pemphigus. Dermatology 192:373-374.
240. Rushton A (1977). Safety of Hibitane. II. Human experience. J Clin Periodontol 4(5):73-79.
241. Sabroe RA, Black AK (1997). Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br J Dermatol 136:153-158.
242. Savino LB, Haushalter NM (1992). Lisinopril-induced "scalded mouth syndrome". Ann Pharmacother 26:1381-1382.
243. Schachter M (1999). Moxonidine: a review of safety and tolerability after seven years of clinical experience. J Hypertens 17(Suppl 3):S37-S39.
244. Schatzberg AF (2000). Clinical efficacy of reboxetine in major depression. J Clin Psychiatry 61(Suppl 10):31-38.
245. Schier JG, Hoffman RS, Nelson LS (2002). Desiccant-induced gastrointestinal burns in a child. Vet Hum Toxicol 44:343-344.
246. Schubert MM (1991). Oral manifestations of viral infections in immunocompromised patients. Curr Opin Dent 1:384-397.
247. Schubert MM, Epstein JB, Lloid ME, Cooney E (1993). Oral infections due to cytomegalovirus in immunocompromised patients. J Oral Pathol Med 22:268-273.
248. Sciubba JJ (1995). Oral leukoplakia. Crit Rev Oral Biol Med 6:147-160.
249. Scott BB (1998). Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 12:277-279.
250. Scott LJ, Perry CM (2000). Tramadol: a review of its use in perioperative pain. Drugs 60:139-176.
251. Scully C (1992). Oral infections in the immunocompromised patient. Br Dent J 172(11):401-407.
252. Scully C (2003). Drug effects on salivary glands; dry mouth. Oral Dis 9:165-176.
253. Scully C, Challacombe SJ (2002). Pemphigus vulgaris: update on etiopathogenesis, oral manifestations, and management. Crit Rev Oral Biol Med 13:397-408.
254. Scully C, Diz DP (2001). Orofacial effects of antiretroviral therapies. Oral Dis 7:205-210.
255. Scully C, Porter SR (1997). The clinical spectrum of desquamative gingivitis. Semin Cutan Med Surg 16:308-313.
256. Scully C, El Kabir M, Samaranayake LP (1994). Candida and oral candidosis: a review. Crit Rev Oral Biol Med 5:125-157.
257. Scully C, Beyli M, Ferreiro MC, Ficarra G, Gill Y, Griffiths M, et al. (1998). Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 9:86-122.
258. Scully C, El Kabir M, Greenman J, Porter SR, Mutlu S, Barton I, et al. (1999). The effects of mouth rinses and dentifrice-containing magnesium monoperoxyphthalate (mmpp) on oral microflora, plaque reduction, and mucosa. J Clin Periodontol 26:234-238.
259. Scully C, Bagan J, Eisen D, Porter S, Rogers R (2000). Dermatology of the lips. Oxford: Isis Medical Media.
260. Seedat YK (1979). Aphthous ulcers of mouth from captopril. Lancet 2:1297-1298.
261. Sekine Y, Rikihisa T, Ogata H, Echizen H, Arakawa Y (1999). Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions. Eur J Clin Pharmacol 55:583-587.
262. Seymour RA, Jacobs DJ (1992). Cyclosporin and the gingival tissues. J Clin Periodontol 19:1-11.
263. Seymour RA, Thomason JM, Nolan A (1997). Oral lesions in organ transplant patients. J Oral Pathol Med 26(7):297-304.
264. Shapiro M, Jimenez S, Werth VP (2000). Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis. J Am Acad Dermatol 42:297-299.
265. Shotts RH, Scully C, Avery CM, Porter SR (1999). Nicorandil-induced severe oral ulceration: a newly recognized drug reaction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87:706-707.
266. Shrivastava RK, Cohn C, Crowder J, Davidson J, Dunner D, Feighner J, et al. (1994). Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. J Clin Psychopharmacol 14:322-329.
267. Shuttleworth D, Graham-Brown RA, Hutchinson PE, Jolliffe DS (1985). Cicatricial pemphigoid in D-penicillamine treated patients with rheumatoid arthritis - a report of three cases. Clin Exp Dermatol 10:392-397.
268. Siegel MA, Balciunas BA (1991). Medication can induce severe ulcerations. J Am Dent Assoc 122:75-77.
269. Skoglund A, Egelrud T (1991). Hypersensitivity reactions to dental materials in patients with lichenoid oral mucosal lesions and in patients with burning mouth syndrome. Scand J Dent Res 99:320-328.
270. Smart ER, Macleod RI, Lawrence CM (1995). Resolution of lichen planus following removal of amalgam restorations in patients with proven allergy to mercury salts: a pilot study. Br Dent J 178:108-112.
271. Smith RG, Burtner AP (1994). Oral side-effects of the most frequently prescribed drugs. Spec Care Dentist 14:96-102.
272. Sproule BA, Busto UE, Buckle C, Herrmann N, Bowles S (1999). The use of non-prescription sleep products in the elderly. Int J Geriatr Psychiatry 14:851-857.
273. Sreebny LM, Schwartz SS (1997). A reference guide to drugs and dry mouth. 2nd ed. Gerodontology 14:33-47.
274. Srisurapanont M, Disayavanish C, Taimkaew K (2000). Quetiapine for schizophrenia. Cochrane Database Syst Rev (2):CD000967.
275. Streckfus CF (1995). Salivary function and hypertension: a review of the literature and a case report. J Am Dent Assoc 126:1012-1017.
276. Stricker BH, Van Riemsdijk MM, Sturkenboom MC, Ottervanger JP (1996). Taste loss to terbinafine: a case-control study of potential risk factors. Br J Clin Pharmacol 42:313-318.
277. Suzuki N, Saito K, Shiota T, Akizuki H, Michiwaki Y, Ohno K, et al. (1983). [Fundamental and clinical studies of long acting amoxicillin granules in oral and maxillofacial surgery infections]. Jpn J Antibiot 36:452-463.
278. Syrjanen SM, Syrjanen KJ (1979). Hyperplastic gingivitis in a child receiving sodium valproate treatment. Proc Finn Dent Soc 75:95-98.
279. Taricco M, Adone R, Pagliacci C, Telaro E (2000). Pharmacological interventions for spasticity following spinal cord injury. Cochrane Database Syst Rev (2):CD001131.
280. Teare JP, Spedding C, Whitehead MW, Greenfield SM, Challacombe SJ, Thompson RP (1995). Omeprazole and dry mouth. Scand J Gastroenterol 30:216-218.
281. Thomason JM, Kelly PJ, Seymour RA (1996). The distribution of gingival overgrowth in organ transplant patients. J Clin Periodontol 23:367-371.
282. Thomson WM, Chalmers JM, Spencer AJ, Slade GD (2000). Medication and dry mouth: findings from a cohort study of older people. J Public Health Dent 60:12-20.
283. Thomson WM, Spencer AJ, Slade GD, Chalmers JM (2002). Is medication a risk factor for dental caries among older people? Community Dent Oral Epidemiol 30:224-232.
284. Timms MS, Sloan P, Balzan AP (1988). Idiopathic plasmacytosis of the oral and supraglottic mucosa. J Laryngol Otol 102:646-648.
285. Tohen M, Chengappa KN, Suppes T, Zarate CA Jr, Calabrese JR, Bowden CL, et al. (2002). Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 59:62-69.
286. Toren A, Ackerstein A, Gazit D, Or R, Raveh D, Kupolovicz U, et al. (1996). Oral tuberculosis following autologous bone marrow transplantation for Hodgkin's disease with interleukin-2 and alpha-interferon immunotherapy. Bone Marrow Transplant 18:209-210.
287. Torrelo A, Soria C, Rocamora A, Moreno R, Ledo A (1990). Lichen planus-like eruption with esophageal involvement as a result of cyanamide. J Am Acad Dermatol 23:1168-1169.
288. Torresani C, Nannini R, Bondi A, Guadagni M, Manara GC (1994). Erosive oral lichen planus due to sensitization to cobalt chloride. Clin Exp Dermatol 19:535-536.
289. Triantos D, Porter SR, Scully C, Teo CG (1997). Oral hairy leukoplakia: clinicopathologic features, pathogenesis, diagnosis, and clinical significance. Clin Infect Dis 25:1392-1396.
290. Trindade E, Menon D, Topfer LA, Coloma C (1998). Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. CMAJ 159:1245-1252.
291. Troy JL, Silvers DN, Grossman ME, Jaffe IA (1981). Penicillamine- associated pemphigus: is it really pemphigus? J Am Acad Dermatol 4:547-555.
292. Tur E, Brenner S (1998). Diet and pemphigus. In pursuit of exogenous factors in pemphigus and fogo selvagem. Arch Dermatol 134:1406-1410.
293. Ulmer JL, Garvey MJ (1992). Fatal angioedema associated with lisinopril. Ann Pharmacother 26:1245-1246.
294. Valentine C, Deenmamode J, Sherwood R (1992). Xerostomia associated with didanosine. Lancet 340:1542-1543.
295. Valsecchi R, Cainelli T (1992). Gingival hyperplasia induced by erythromycin. Acta Derm Venereol 72:157.
296. Van den Haute V, Antoine JL, Lachapelle JM (1989). Histopathological discriminant criteria between lichenoid drug eruption and idiopathic lichen planus: retrospective study on selected samples. Dermatologica 179:10-13.
297. Van Dis ML, Parks ET (1995). Prevalence of oral lichen planus in patients with diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79:696-700.
298. van Gelder T, ter Meulen CG, Hene R, Weimar W, Hoitsma A (2003). Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil. Transplantation 75:788-791.
299. van Joost T (1974). Incidence of circulating antibodies reactive with basal cells of skin in drug reactions. Acta Derm Venereol 54:183-187.
300. Varga E, Tyldesley WR (1991). Carcinoma arising in cyclosporin-induced gingival hyperplasia. Br Dent J 171:26-27.
301. Vasile JS, Steingard S (1995). Clozapine and the development of salivary gland swelling: a case study. J Clin Psychiatry 56:511-513.
302. Vassileva S (1998). Drug-induced pemphigoid: bullous and cicatricial. Clin Dermatol 16:379-387.
303. Velthuis PJ, Hendrikse JC, Nefkens JJ (1985). Combined features of pemphigus and pemphigoid induced by penicillamine. Br J Dermatol 112:615-619.
304. Versi E, Appell R, Mobley D, Patton W, Saltzstein D (2000). Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group. Obstet Gynecol 95:718-721.
305. Versiani M, Cassano G, Perugi G, Benedetti A, Mastalli L, Nardi A, et al. (2002). Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. J Clin Psychiatry 63:31-37.
306. Vissink A, van Nieuw Amerongen A, Wesseling H, and 's-Gravenmade EJ (1992). [Dry mouth; possible cause - pharmaceuticals]. Ned Tijdschr Tandheelkd 99(3):103-112.
307. Vlasses PH, Rotmensch HH, Ferguson RK, Sheaffer SL (1982). "Scalded mouth" caused by angiotensin-converting-enzyme inhibitors. Br Med J (Clin Res Ed) 284:1672-1673.
308. Vleeming W, van Amsterdam JG, Stricker BH, De Wildt DJ (1998). ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Safety 18:171-188.
309. Wadworth AN, McTavish D (1993). Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs Aging 3:441-459.
310. Wahlbeck K, Cheine M, Essali MA (2000). Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database Syst Rev (2):CD000059.
311. Watson IB, MacDonald DG (1974). Amodioquine induced oral pigmentation - a light and electron microscopic study. J Oral Pathol 3:16-21.
312. Watt-Smith S, Mehta K, Scully C (2001). Mefloquine-induced trigeminal sensory neuropathy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:163-165.
313. Weintraub M, Sundaresan PR, Schuster B, Ginsberg G, Madan M, Balder A, et al. (1992). Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise. Clin Pharmacol Ther 51:595-601.
314. Wellington K, Jarvis B (2001). Cetirizine/pseudoephedrine. Drugs 61:2231-2240.
315. Wellington K, Perry CM (2001). Venlafaxine extended-release: a review of its use in the management of major depression. CNS Drugs 15:643-669.
316. Westbury LW, Najera A (1997). Minocycline-induced intraoral pharmacogenic pigmentation: case reports and review of the literature. J Periodontol 68:84-91.
317. White JW Jr, Olsen KD, Banks PM (1986). Plasma cell orificial mucositis. Report of a case and review of the literature. Arch Dermatol 122:1321-1324.
318. Wiesenfeld D, Martin A, Scully C, Thomson J (1982). Oral manifestations in linear IgA disease. Br Dent J 153:398-399.
319. Winner P, Lewis D, Visser WH, Jiang K, Ahrens S, Evans JK (2002). Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache 42:49-55.
320. Wishart JM, Hodge JL, Greig DE (1981). Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro-10-9359) Tigason. NZ Med J 94:307-308.
321. Wolf R, Brenner S (1994). An active amide group in the molecule of drugs that induce pemphigus: a casual or causal relationship? Dermatology 189:1-4.
322. Wolf R, Ruocco V (1997). Gaining more insight into the pathomechanisms of thiol-induced acantholysis. Med Hypotheses 48:107-110.
323. Wolf R, Tamir A, Brenner S (1991). Drug-induced versus drug-triggered pemphigus. Dermatologica 182(4):207-210.
324. Wynn RL, Meiller TF (2001). Drugs and dry mouth. Gen Dent 49:10-12, 14.
325. Zacny JP (2001). Morphine responses in humans: a retrospective analysis of sex differences. Drug Alcohol Depend 63:23-28.
326. Zinner NR, Mattiasson A, Stanton SL (2002). Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients. J Am Geriatr Soc 50:799-807.
327. Zwar N, Richmond R (2002). Bupropion sustained release. A therapeutic review of Zyban. Aust Fam Physician 31:443-447.